COVID-19 has claimed the lives of about 18 million people. Researchers are working around the clock to better understand, cure, and finally eradicate COVID-19 and the sickness that comes with it. WHO and its partners are dedicated to developing COVID-19 vaccines as quickly as possible while maintaining the highest safety requirements. Vaccines go through several stages of research and testing - clinical trials typically have three phases, the last of which is aimed to examine the product's capacity to protect against disease, known as effectiveness. Each phase evaluates the level of risk. Vaccines have previously been developed through a sequence of steps that can take years to complete. Given the critical need for COVID-19 vaccines, enormous financial investments and scientific collaborations are now transforming vaccine development.
 
                                 
                                 
                                 
                                 
                                 
                                 
                             
                             
                             
                            
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain
Title : Mathematical modeling of COVID-19 dynamics in a West African context
Christabel Emaeyak James, University of Glasgow, United Kingdom
Title : Severe influenza and other related respiratory infection cases during Omicron era in Japan
Masafumi Seki, Saitama Medical University International Medical Center, Japan